Abstract
Plasma concentrations were measured in 10 patients with rheumatoid arthritis taking 250 mg, 500 mg and 750 mg of D-penicillamine daily. A disproportionate rise in the dose adjusted area under the plasma concentration vs time curve suggested dose dependent kinetics for D-penicillamine. Marked interindividual variability was seen with pharmacokinetic parameters and no correlations were observed between side effects or response and plasma concentrations of reduced D-penicillamine.
Original language | English |
---|---|
Pages (from-to) | 772-775 |
Number of pages | 4 |
Journal | Journal of Rheumatology |
Volume | 11 |
Issue number | 6 |
Publication status | Published - 1 Dec 1984 |